It was only a matter of time until the GLP-1 receptor agonist drugs like Ozempic and Wegovy were superseded, and now it looks ...
Work is continuing so that the drug, and similar medicines, can be issued under medical card schemes to slash costs.
The European Medicines Agency (EMA) has advised that the drug can be used together with diet and physical activity to help ...